Partner Content Partner Content Exclusive interview with Team Consulting released for Inject... Exclusive interview with Team Consulting released
News Positive Ph1 results for AC Immune's NLRP3 inflammasome inhi... AC Immune has announced positive interim results from its Ph 1 study of ACI-19764 – a NLRP3 inflammasome inhibitor targeting chronic inflammation.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
